Products for Research Use Only
RegisterLogin

Relugolix

CAT: 0013-GTR19171069-01Size: 2 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19171069-01Size:2 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Relugolix is an oral GnRH receptor antagonist that suppresses LH and FSH release, leading to reduced testosterone production. This mechanism is applied in research for hormone-dependent cancers like prostate cancer, utilizing both in vitro receptor binding assays and in vivo xenograft models to study its antineoplastic effects.
CAS Number
737789-87-6
Product Name Alternative
Antagonistic, Inhibitor, GnRH Receptor, GnRH, GNRHR, GnRHR, GNRH Receptor, GNRHReceptor, Gonadotropin releasing hormone receptor, FSH, endometriosis, inhibit, prostate cancer, TAK 385, TAK385, TAK-385, RVT 601, RVT601, RVT-601, Relugolix, uterine fibroid
Field of Research
Pharmacology & Drug Discovery
Purity
98.64% (May vary between batches)
Solubility
DMSO:250 mg/mL (400.88 mM) ;10% DMSO+40% PEG300+5% Tween-80+45% Saline:1 mg/mL (1.6 mM)
Smiles
CONC (=O) Nc1ccc (cc1) -c1sc2n (Cc3c (F) cccc3F) c (=O) n (-c3ccc (OC) nn3) c (=O) c2c1CN (C) C
Molecular Formula
C29H27F2N7O5S
Molecular Weight
623.63
Storage Conditions
-20°C
Notes
For research use only.

Alternative Products

CatalogName
BA5360-5.1Relugolix
A17783-50Relugolix 50mg
CS-O-42923Relugolix-d6
HY-16474R-01Relugolix (Standard)
A17783-1Relugolix 1mg

Popular Products